September 2, 2020

Amyris Scales First Fermentation-Based CBG

Amyris, a synthetic biotechnology company specializing in cosmetics, flavors, and fragrances, has successfully scaled up production of Cannabigerol (CBG), a non-psychoactive cannabinoid. Often referred to as “the stemcell of cannabinoids,” CBG is the precursor from which all other cannabinoids are synthesized and is purported to…

Read More »

Amyris Scales First Fermentation-Based CBG

Amyris, a synthetic biotechnology company specializing in cosmetics, flavors, and fragrances, has successfully scaled up production of Cannabigerol (CBG), a non-psychoactive cannabinoid. Often referred to as “the stemcell of cannabinoids,” CBG is the precursor from which all other cannabinoids are synthesized and is purported to…

Read More »

Join the List

Subscribe for weekly updates.

We value your privacy.
Scroll to Top